We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Early Predictors of In-Hospital Mortality for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome

Richard Charney, MD
Arch Intern Med. 1988;148(3):747. doi:10.1001/archinte.1988.00380030253041.
Text Size: A A A
Published online


To the Editor.  —In the August 1987 issue of the Archives, Kales et al1 analyzed clinical and laboratory data in 145 patients with Pneumocystis carinii pneumonia (PCP). They identified the following variables that were associated with increased in-hospital mortality: multiple admissions, leukocytosis, elevated lactic dehydrogenase levels, decreased oxygen pressure (tension) and carbon dioxide (tension), decreased serum albumin levels, and concurrent pulmonary infections. Patients with normal respiratory rates and normal chest examinations had increased survival rates.The authors fail to indicate the drugs that were used to treat the patients. Sulfamethoxazole and trimethoprim and pentamidine are both effective in treating PCP. However, the use of sulfamethoxazole and trimethoprim should be avoided in patients with a history of allergy to its components or patients who require fluid restriction, since intravenous administration requires at least 1200 mL of fluid daily. Sulfamethoxazole and trimethoprim is the drug of choice in patients with preexisting


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.